ArticleNature2021
COVID super-immunity: one of the pandemic's great puzzles.
Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- CKD-related impairment in humoral and cellular immune response and potential correlation with long COVID-19: a systematic review.Frontiers in immunology · 2025Pooled it
- Article
- Optimal evaluation of re-opening policies for COVID-19 through the use of metaheuristic schemes.Applied mathematical modelling · 2023Article
- Serological Response to SARS-CoV-2 Vaccine in Hemodialyzed Patients and the Association with Later COVID-19 Positivity.Antibodies (Basel, Switzerland) · 2023Article
- Simulation of the COVID-19 handling policy in Indonesia.Journal of public health in Africa · 2023Article
- SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants.Cell discovery · 2022Article
- An agent-based transmission model of COVID-19 for re-opening policy design.Computers in biology and medicine · 2022Article
- Antibody-Mediated Immunogenicity Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Following Priming, Boosting, and Hybrid Immunity: Insights From 11 Months of Follow-up of a Healthcare Worker Cohort in Israel, December 2020-October 2021.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- Association of neutralizing breadth against SARS-CoV-2 with inoculation orders of heterologous prime-boost vaccines.Med (New York, N.Y.) · 2022Article
- Sputnik-V reactogenicity and immunogenicity in the blood and mucosa: a prospective cohort study.Scientific reports · 2022Article
- Development of an in-house quantitative ELISA for the evaluation of different Covid-19 vaccines in humans.Scientific reports · 2022Article
- Superimmunity by pan-sarbecovirus nanobodies.Cell reports · 2022Article
- Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2.The New England journal of medicine · 2022Article
- Anti-coronavirus vaccines will not accelerate the transition of humanity to a non-pandemic period, but the pandemic will take fewer victims.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022Review
- Article
- COVID-19 vaccination reduces mortality in patients on maintenance hemodialysis.Frontiers in medicine · 2022Article
- Caregivers' Attitudes Toward COVID-19 Vaccination in Children and Adolescents With a History of SARS-CoV-2 Infection.Frontiers in pediatrics · 2022Article
- Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients.Vaccines · 2021Article
- Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
34650244What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.